Results 181 to 190 of about 116,059 (245)

Diabetic kidney disease, biomarkers, and finerenone

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Diabetic kidney disease (DKD), the leading cause of kidney failure worldwide, is associated with an increased risk of cardiovascular disease (CVD). A complex pathobiology involving hemodynamic, metabolic, and immune dysregulation promotes inflammatory and fibrotic pathways that contribute to kidney disease progression and CVD in individuals ...
Ashish Verma, Ashish Upadhyay
wiley   +1 more source

Case Report: Maximizing the anti-proteinuric response: a multicenter real-world sparsentan case series in IgA disorders. [PDF]

Front Nephrol
Ray AS, Errabelli P, Lathiya M, Mareedu N.   +3 more
europepmc   +1 more source

Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double‐blind, placebo‐controlled trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The precise mechanism of sodium glucose co‐transporter 2 (SGLT2) inhibitor on reno‐protective effect has been still unclear. In this study, we hypothesised that SGLT2 inhibitor prevents diabetic kidney disease via reduction of hypoxia‐induced factors.
Hisashi Makino, Masato Kasahara, Ryuzo Takashima, Shu Kasama, Naoki Ozu, Hyohun Park, Qingxing Chen, Kazuhiko Tsuruya, Mayu Tochiya, Yoko Omura‐Ohata, Tamiko Tamanaha, Michio Noguchi, Takeshi Aiba, Fumiki Yoshihara, Kiminori Hosoda   +14 more
wiley   +1 more source

Repeat kidney biopsy reveals new-onset IgA nephropathy in a patient with ANCA-associated vasculitis. [PDF]

CEN Case Rep
Iwami S, Eriguchi M, Kosugi T, Furuyama R, Kitamura S, Tanabe K, Matsui M, Samejima KI, Tsuruya K.   +8 more
europepmc   +1 more source

SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Randomized controlled trials on sodium‐glucose cotransporter 2 (SGLT2) inhibitors have yielded inconsistent findings regarding mortality benefits. It remains unclear whether, and in which subgroups, SGLT2 inhibitors confer survival benefits in older adults with diabetic kidney disease (DKD).
Tatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, Yuta Suzuki, Toshiyuki Ko, Kazuki Aoyama, Takashin Nakayama, Yuya Kimura, Katsuhiko Fujiu, Norifumi Takeda, Hiroyuki Morita, Takashi Yokoo, Koichi Node, Masaomi Nangaku, Norihiko Takeda, Hideo Yasunaga, Kaori Hayashi   +16 more
wiley   +1 more source

No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study. [PDF]

Cancers (Basel)
Ueshima K, Nishida N, Hagiwara S, Minami Y, Ida H, Takita M, Chishina H, Morita M, Aoki T, Hamano T, Take R, Watanabe C, Asoh K, Tanaka A, Kudo M.   +14 more
europepmc   +1 more source

DESAFIO DO NUTCRACKER SYNDROME CAUSA DE HEMATÚRIA E PROTEINÚRIA NÃO GLOMERULAR RELATO DE CASO

Solanghe Esquivel Pazmino, Maria Célia Carvalho   +1 more
openalex   +1 more source

Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment

European Journal of Haematology, EarlyView.
ABSTRACT Background Severe renal insufficiency requiring dialysis in newly diagnosed multiple myeloma (NDMM) patients has been independently associated with poor survival outcomes. However, there is a paucity of data on factors predicting renal recovery and survival outcomes of these patients.
Rintu Sharma, Eshetu G. Atenafu, Esther Masih‐Khan, Harjot Vohra, Sita Bhella, Christine Chen, Vishal Kukreti, Guido Lancman, Anca Prica, A. Keith Stewart, Rodger Tiedemann, Suzanne Trudel, Chloe Yang, Donna Reece   +13 more
wiley   +1 more source

Association Between New-Onset Proteinuria During Hospitalization and Cardiovascular Mortality Among Patients With Atherosclerotic Cardiovascular Disease. [PDF]

JACC Adv
Su L, Chen R, Zhou S, Guo Z, Li Y, Zhang X, Luo F, Gao Q, Lin Y, Cao L, Liu J, Pang M, She C, Xu X, Nie S.   +14 more
europepmc   +1 more source

EXPERIÊNCIA LOCAL COM FINERENONA EM PACIENTES COM DOENÇA RENAL DIABÉTICA E PROTEINÚRIA: IMPACTO EM MARCADORES RENAIS NO SEGUIMENTO AMBULATORIAL

Tiago Lemos Cerqueira, Breno Santos Amaral, Luiza Jardim Auarek, Marcela Carolina Passini, Jessica de Cassia Mendes Eleutério, Leonor Carmo   +5 more
openalex   +1 more source